Semtech Corporation (SMTC)
NASDAQ: SMTC · Real-Time Price · USD
51.69
+1.55 (3.09%)
At close: Aug 4, 2025, 4:00 PM
51.78
+0.09 (0.17%)
After-hours: Aug 4, 2025, 6:03 PM EDT
Elevation Oncology Stock Forecast
Stock Price Forecast
The 12 analysts that cover Elevation Oncology stock have a consensus rating of "Strong Buy" and an average price target of $60.83, which forecasts a 17.68% increase in the stock price over the next year. The lowest target is $43 and the highest is $85.
Price Target: $60.83 (+17.68%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Elevation Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $45 → $54 | Strong Buy | Maintains | $45 → $54 | +4.47% | Jul 18, 2025 |
| Stifel | Stifel | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | -12.94% | May 28, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $40 → $43 | Hold | Maintains | $40 → $43 | -16.81% | May 28, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $68 | Strong Buy | Reiterates | $68 | +31.55% | May 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $54 | Strong Buy | Reiterates | $54 | +4.47% | May 28, 2025 |
Financial Forecast
Revenue This Year
1.05B
from 909.29M
Increased by 15.81%
Revenue Next Year
1.16B
from 1.05B
Increased by 9.69%
EPS This Year
1.69
from -2.26
EPS Next Year
2.19
from 1.69
Increased by 29.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | 1.2B | 1.3B |
| Avg | 1.1B | 1.2B | 1.2B |
| Low | 938.9M | 898.4M | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.5% | 18.1% | 12.7% |
| Avg | 15.8% | 9.7% | 7.3% |
| Low | 3.3% | -14.7% | 1.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.85 | 2.63 | 3.86 |
| Avg | 1.69 | 2.19 | 3.00 |
| Low | 1.55 | 1.87 | 2.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 55.0% | 76.1% |
| Avg | - | 29.6% | 36.9% |
| Low | - | 10.5% | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.